# Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

> **NCT01196104** · PHASE3 · TERMINATED · sponsor: **Mannkind Corporation** · enrollment: 39 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Technosphere® Insulin Inhalation Powder
- **DRUG:** Insulin Aspart
- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT01196104
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-08
- **Final completion:** 2012-03
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** For Business Reasons
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01196104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01196104, "Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01196104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*